Beigani

Sobre este medicamento

Originator: Alunbrig by ARIAD Pharmaceuticals · Manufacturer: TLPH Pharma. Indication & Dosage: Beigani (Brigatinib), generic ALUNBRIG/Alanbrig is the prescription medicine used to treat anaplastic lymphoma kinase-positive (LUCIBRIGA+) metastatic non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Beigani Manufactured by TLPH Pharma ltd. in Laos. Brigatinib has to take orally once a day with or without food. After the first 7 days if tolerated, healthcare provider may increase dose to 180 mg orally once daily. Side Effects: The most common adverse reactions of Brigatinib are: Nausea / vomiting , diarrhea , decreased appetite, abdominal pain, constipation, tiredness, dizziness , fever, headache , trouble sleeping, or joint pain. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.